[go: up one dir, main page]

BR9909044A - Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante - Google Patents

Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante

Info

Publication number
BR9909044A
BR9909044A BR9909044-9A BR9909044A BR9909044A BR 9909044 A BR9909044 A BR 9909044A BR 9909044 A BR9909044 A BR 9909044A BR 9909044 A BR9909044 A BR 9909044A
Authority
BR
Brazil
Prior art keywords
nucleic acid
acid transfer
transfer vector
cells
composition
Prior art date
Application number
BR9909044-9A
Other languages
English (en)
Inventor
Carole Ciolina
Daniel Scherman
Pierre Wils
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR9909044A publication Critical patent/BR9909044A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"VETOR DE TRANSFERêNCIA DE áCIDOS NUCLEICOS, COMPOSIçãO, UTILIZAçãO DE UM VETOR DE TRANSFERêNCIA DE áCIDOS NUCLEICOS, PROCESSOS DE TRANSFECçãO DE áCIDOS NUCLEICOS NAS CéLULAS, E DE TRATAMENTO DE DOENçAS, E, CéLULA RECOMBINANTE". A presente invenção refere-se a novos vetores e sua utilização para a transferência de ácidos nucleicos. Mais particularmente, a invenção refere-se a novos vetores capazes de dirigir os ácidos nucleicos para as células ou os compartimentos celulares específicos.
BR9909044-9A 1998-03-24 1999-03-19 Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante BR9909044A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (fr) 1998-03-24 1998-03-24 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (fr) 1998-03-24 1999-03-19 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Publications (1)

Publication Number Publication Date
BR9909044A true BR9909044A (pt) 2000-12-05

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909044-9A BR9909044A (pt) 1998-03-24 1999-03-19 Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante

Country Status (12)

Country Link
EP (1) EP1066396A1 (pt)
JP (1) JP2002507429A (pt)
KR (1) KR20010074456A (pt)
CN (1) CN1292827A (pt)
AU (1) AU758406B2 (pt)
BR (1) BR9909044A (pt)
CA (1) CA2323831A1 (pt)
HU (1) HUP0102413A3 (pt)
IL (1) IL138624A0 (pt)
NO (1) NO20004648D0 (pt)
PL (1) PL342944A1 (pt)
WO (1) WO1999049067A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287662B6 (sk) * 2000-05-26 2011-05-06 Centelion Spôsob purifikácie dvojvláknovej DNA použitím imobilizovaného oligonukleotidu
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
EP1913141A2 (en) * 2005-06-03 2008-04-23 The CBR Institute for Biomedical Research, Inc. Sirna microbicides for preventing and treating viral diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
US11237163B2 (en) * 2016-03-07 2022-02-01 Quidel Cardiovascular Inc. Immunoassay controls and the use thereof
RU2731513C2 (ru) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
AU2024246251A1 (en) * 2023-03-24 2025-08-28 Adcytherix Sas Nuclear localization polypeptides and conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2028792A (en) * 1991-05-17 1992-12-30 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique

Also Published As

Publication number Publication date
KR20010074456A (ko) 2001-08-04
HUP0102413A3 (en) 2003-09-29
NO20004648L (no) 2000-09-18
EP1066396A1 (fr) 2001-01-10
CN1292827A (zh) 2001-04-25
AU3406200A (en) 2000-12-14
CA2323831A1 (fr) 1999-09-30
HUP0102413A1 (hu) 2001-10-28
NO20004648D0 (no) 2000-09-18
WO1999049067A1 (fr) 1999-09-30
IL138624A0 (en) 2001-10-31
JP2002507429A (ja) 2002-03-12
PL342944A1 (en) 2001-07-16
AU758406B2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
EP1322307A4 (en) METHOD FOR THE TREATMENT OF CELL PROLIFERATION TROUBLES AND VIRUS INFECTIONS
BG102554A (en) Vectors and methods for gene transfer into cells
BR9910251A (pt) Estimulação hematopoiética
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
BR0007663A (pt) Derivados de acila para uso no tratamento de doenças relacionadas com o vla-4
MX9800719A (es) Proteinas de transporte y sus usos.
BR0010496A (pt) Regulação da expressão genica viral
DE50013093D1 (de) Sequenz-spezifische dna-rekombination in eukaryotischen zellen
DK0506884T3 (da) Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
FR2470794A1 (fr) Nouvelles microparticules, leur preparation et leurs applications en biologie, notamment a la culture de cellules diploides humaines
CY1108603T1 (el) Συστηματα πρωτεϊνων μεταφορας λιπιδιων και η καλλυντικη δερματολογικη εφαρμογη τους
BR0009964A (pt) Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
CY1109367T1 (el) Συνθεσεις και μεθοδοι για ενισχυση της παροχης θεραπευτικων παραγοντων σε κυτταρα
PT998501E (pt) Polimeros cationicos complexos associando os referidos polimeros cationicos e substancias terapeuticamente activas compreendendo pelo menos uma carga negativa especialmente acidos nucleicos e sua utilizacao em terapia genica
WO1999025878A3 (en) Methods for modulating and identifying cellular senescence
FR2662698B1 (pt)
BR9909044A (pt) Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante
TR199802648A2 (xx) Gen tedavisi i�in n�klein asit yap�lar�.
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
WO2000006735A8 (en) Interferon alpha hybrids
CA2385872A1 (en) Gene transfer in human lymphocytes using retroviral scfv cell targeting
BR0014489A (pt) Processos de produção de adenovìrus e de bibliotecas adenovirais, plasmìdeo naveta, bibliotecas de ácido nucleicos e de expressão adenoviral, célula, utilização de adenovìrus e kit
BR9810046A (pt) Sequência de nucleotìdeos, vetor de expressão, célula hospedeira, proteìna de esperma de mamìfero, proteìna de esperma recombinante, proteìna 4, 1 e/ou 6,7 de esperma, composição farmacêutica, e, vacina contraceptiva

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.